Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Five Year Experience of Acute Intrahepatic Cholestasis in Patients with Sickle Cell Disease at a Large Teaching Hospital in London

Anne Nkirote Mwirigi, MBChB, Chengetai Muzah, Liz Odeh, Abid Suddle, Swee Lay Thein, MD DSc, Moji Awogbade

Blood (2015) 126 (23): 3416.

https://doi.org/10.1182/blood.V126.23.3416.3416

Published: 2015

Journal Articles

Fucosylation Inhibitor, 2-Fluorofucose, Inhibits NF-κB Activation and Vaso-Occlusion In Transgenic Sickle Mice

John D Belcher, Ph.D., Chunsheng Chen, Julia Nguyen, Nicole M. Okeley, PhD, Peter D. Senter, PhD, Dennis R. Benjamin, PhD, Gregory M Vercellotti

Blood (2013) 122 (21): 730.

https://doi.org/10.1182/blood.V122.21.730.730

Published: 2013

Journal Articles

MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide, Inhibits Microvascular Stasis in Transgenic Sickle Mice Through Heme Oxygenase-1.

John D Belcher, PhD, Chunsheng Chen, PhD, Mark Young, PhD, Kenneth Burhop, PhD, Gregory M Vercellotti, MD

Blood (2012) 120 (21): 2112.

https://doi.org/10.1182/blood.V120.21.2112.2112

Published: 2012

Journal Articles

Prevention of Venular Stasis, Circulatory Collapse and Mortality in Transgenic Sickle Mice Administered MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide

John D Belcher, PhD, Chunsheng Chen, PhD, Mark Young, PhD, Phuc Tran, Gregory M Vercellotti, MD

Blood (2011) 118 (21): 850.

https://doi.org/10.1182/blood.V118.21.850.850

Published: 2011

Journal Articles

Plasma Hemoglobin and Heme Trigger Weibel Palade Body Exocytosis and Vaso-Occlusion in Transgenic Sickle Mice

John D Belcher, PhD, Julia Nguyen, Chunsheng Chen, PhD, Ann Smith, PhD, Abdu I Alayash, PhD, DSc, Sethu L Nair, PhD, Arif Somani, MD, Robert P Hebbel, MD, Gregory M Vercellotti, MD

Blood (2011) 118 (21): 896.

https://doi.org/10.1182/blood.V118.21.896.896

Published: 2011

Journal Articles

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

Robert P. Hebbel, Gregory M. Vercellotti, Betty S. Pace, Anna N. Solovey, Rahn Kollander, Chine F. Abanonu, Julia Nguyen, Julie V. Vineyard, John D. Belcher, Fuad Abdulla, Shadé Osifuye, John W. Eaton, Robert J. Kelm, Jr, Arne Slungaard

Blood (2010) 115 (12): 2483–2490.

https://doi.org/10.1182/blood-2009-02-204990

Published: 2010

Journal Articles

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Robert P Hebbel, MD, Gregory M. Vercellotti, MD, Betty Pace, MD, Anna Solovey, M.D., Rahn Kollander, Chine Abanonu, Julia Nguyen, BS, Julie V. Vineyard, BS, John D Belcher, Ph.D., Fuad Abdulla, Shade Osifuye, John W. Eaton, PhD, Robert Kelm, MD, Arne Slungaard, MD

Blood (2009) 114 (22): 2586.

https://doi.org/10.1182/blood.V114.22.2586.2586

Published: 2009

Journal Articles

Heme Oxygenase-1 Gene Therapy in a Murine Model of Sickle Cell Disease.

Belcher D. Belcher, Ph.D., Julie V. Vineyard, BS, Carol M Bruzzone, MS, Chunsheng Chen, M.D./Ph.D., Joan D Beckman, BS, Julia Ngyuen, BS, Clifford J Steer, M.D., Gregory M. Vercellotti, MD

Blood (2009) 114 (22): 1527.

https://doi.org/10.1182/blood.V114.22.1527.1527

Published: 2009

Journal Articles

Influence of Phlebotomies on Arterial Hemodynamic Parameters in Polycythemia Vera Patients.

Anatoly Nemets, MD, Josef Barshai, MD, Shmuel Oren, MD, Irina Isakov, MD, Gilles Lugassy, MD

Blood (2005) 106 (11): 4945.

https://doi.org/10.1182/blood.V106.11.4945.4945

Published: 2005

Journal Articles

Tissue Factor Deficiency Decreases Sickle Cell-Induced Vascular Stasis in a Hematopoietic Stem Cell Transplant Model of Murine Sickle Cell Disease.

Cheryl A. Hillery, Thomas D. Foster, Sandra L. Holzhauer, J. Paul Scott, Julie A. Panepinto, Narla Mohandas, Nigel Mackman, Nancy J. Wandersee

Blood (2004) 104 (11): 236.

https://doi.org/10.1182/blood.V104.11.236.236

Published: 2004

NARROW

A Five Year Experience of Acute Intrahepatic Cholestasis in Patients with Sickle Cell Disease at a Large Teaching Hospital in London

Fucosylation Inhibitor, 2-Fluorofucose, Inhibits NF-κB Activation and Vaso-Occlusion In Transgenic Sickle Mice

MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide, Inhibits Microvascular Stasis in Transgenic Sickle Mice Through Heme Oxygenase-1.

Prevention of Venular Stasis, Circulatory Collapse and Mortality in Transgenic Sickle Mice Administered MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide

Plasma Hemoglobin and Heme Trigger Weibel Palade Body Exocytosis and Vaso-Occlusion in Transgenic Sickle Mice

The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease.

Heme Oxygenase-1 Gene Therapy in a Murine Model of Sickle Cell Disease.

Influence of Phlebotomies on Arterial Hemodynamic Parameters in Polycythemia Vera Patients.

Tissue Factor Deficiency Decreases Sickle Cell-Induced Vascular Stasis in a Hematopoietic Stem Cell Transplant Model of Murine Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only